Metastatic Disease Clinical Trial Setting
Semantic Scholar uses AI to extract papers important to this topic.
Invasive bladder cancer is a frequently occurring disease with a high mortality rate despite optimal treatment. The… Expand Abstract Background Previous analysis of COMBI-d (NCT01584648) demonstrated improved progression-free survival (PFS) and overall… Expand BACKGROUND
Prostate cancer (PCa) is the second most common disease among men worldwide. It is important to know survival outcomes… Expand BACKGROUND
Cabazitaxel, abiraterone acetate (AA), and enzalutamide have been approved for the treatment of patients with… Expand Metastasis is a leading cause of mortality for osteosarcoma patients. The molecular pathological mechanism remains to be… Expand BACKGROUND
Vismodegib, a first-in-class Hedgehog pathway inhibitor, was US Food and Drug Administration (FDA) approved for… Expand Multiclass brain tumor classification is performed by using a diversified dataset of 428 post-contrast T1-weighted MR images from… Expand PURPOSE
We evaluated the feasibility of administering carboplatin as a radiosensitizer during craniospinal radiation therapy… Expand CCI‐779 is an analog of the immunosuppressive agent, rapamycin, that has demonstrated activity against melanoma in preclinical… Expand Little is known about the genetic regulation of medulloblastoma dissemination, but metastatic medulloblastoma is highly… Expand